Isaoglu U, Ulug P, Delibas I B, Yilmaz M, Kumtepe Y, Dogan H, Tasdemir S
Clin Exp Obstet Gynecol. 2014;41(2):177-81.
To investigate the relation between recurrent pregnancy loss (RPL) and factor V Leiden, prothrombin G20210A, and C677T methylenetetrahydrofolate reductase (MTHFR) mutations.
A case-control study was conducted on 95 consecutive cases with RPL, and 40 age-matched controls who had no history of pregnancy loss and had at least one successful pregnancy. After application of exclusion criteria, 60 patients in the study group and 40 control cases were compared for thrombophilic factors.
Thirteen out of 60 RPL cases and one out of 40 in the control group were carriers of factor V Leiden mutation. While six patients were carriers of prothrombin G20210A gene mutation, none in the control group carried this mutation. Twenty-nine out of 60 RPL cases and 17 out of 40 control cases had MTHFR mutation.
The authors found a positive correlation between RPL and FVL and FII gene mutations, but no significant association between RPL and MTHFR gene mutation.
探讨复发性流产(RPL)与凝血因子V Leiden、凝血酶原G20210A以及C677T亚甲基四氢叶酸还原酶(MTHFR)基因突变之间的关系。
对95例连续的复发性流产病例以及40例年龄匹配的对照者进行病例对照研究,这些对照者无流产史且至少有一次成功妊娠。在应用排除标准后,比较研究组的60例患者和40例对照者的易栓因素。
60例复发性流产病例中有13例以及40例对照者中有1例是凝血因子V Leiden突变携带者。6例患者是凝血酶原G20210A基因突变携带者,而对照组中无人携带此突变。60例复发性流产病例中有29例以及40例对照者中有17例存在MTHFR突变。
作者发现复发性流产与凝血因子V Leiden和凝血酶原基因(FII)突变之间存在正相关,但复发性流产与MTHFR基因突变之间无显著关联。